Evaluation of safety profile of thoracoscopic esophagectomy for T1bN0M0 cancer using data from JCOG0502: a prospective multicenter study

Surgical Endoscopy

Volumn 29, Issue 12, 2015, Pages 3519-3526

  Nozaki, Isao ^a   Kato, Ken ^b   Igaki, Hiroyasu ^b   Ito, Yoshinori ^b   Daiko, Hiroyuki ^c   Yano, Masahiko ^d   Udagawa, Harushi ^e   Mizusawa, Junki ^f   Katayama, Hiroshi ^f   Nakamura, Kenichi ^f   Kitagawa, Yuko ^g  

^a NATIONAL HOSPITAL ORGANIZATION SHIKOKU CANCER CENTER   (Japan)

^b NATIONAL CANCER CENTER HOSPITAL   (Japan)

^c NATIONAL CANCER CENTER HOSPITAL EAST   (Japan)

^d OSAKA MEDICAL CENTER FOR CANCER AND CARDIOVASCULAR DISEASES   (Japan)

^e TORANOMON HOSPITAL   (Japan)

^f NATIONAL CANCER CENTER   (Japan)

^g KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Esophageal cancer; Esophagectomy; Laparoscopy; Minimally invasive surgery; Reoperation; Thoracoscopy

Indexed keywords

ADULT; AGED; ANASTOMOSIS LEAKAGE; ARTICLE; ATELECTASIS; CANCER STAGING; CHEMORADIOTHERAPY; CONTROLLED STUDY; ESOPHAGUS CANCER; ESOPHAGUS RESECTION; FEMALE; HUMAN; INTESTINE OBSTRUCTION; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PARALYTIC ILEUS; PATIENT PREFERENCE; PATIENT SAFETY; PEROPERATIVE COMPLICATION; PNEUMONIA; PRIORITY JOURNAL; PROSPECTIVE STUDY; RECURRENT LARYNGEAL NERVE PALSY; REOPERATION; THORACOSCOPIC ESOPHAGECTOMY; THORACOSCOPY; ADVERSE EFFECTS; CLINICAL TRIAL; ESOPHAGEAL NEOPLASMS; HOSPITAL MORTALITY; INCIDENCE; JAPAN; MIDDLE AGED; MORTALITY; MULTICENTER STUDY; POSTOPERATIVE COMPLICATIONS; PROCEDURES; PULMONARY ATELECTASIS; RANDOMIZED CONTROLLED TRIAL; SAFETY; STATISTICS AND NUMERICAL DATA; SURVIVAL ANALYSIS;

ADULT; AGED; ESOPHAGEAL NEOPLASMS; ESOPHAGECTOMY; FEMALE; HOSPITAL MORTALITY; HUMANS; INCIDENCE; JAPAN; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; PROSPECTIVE STUDIES; PULMONARY ATELECTASIS; REOPERATION; SAFETY; SURVIVAL ANALYSIS; THORACOSCOPY;

EID: 84947492692     PISSN: 09302794     EISSN: 14322218     Source Type: Journal    
DOI: 10.1007/s00464-015-4102-4     Document Type: Article

References (23)

1. Dubecz A, Schwartz SI (2008) Franz John A. Torek. Ann Thorac Surg 85:1497–1499
2. Cuschieri A, Shimi S, Banting S (1992) Endoscopic oesophagectomy through a right thoracoscopic approach. J R Coll Surg Edinb 37:7–11
3. Verhage RJ, Hazebroek EJ, Boone J, Van Hillegersberg R (2009) Minimally invasive surgery compared to open procedures in esophagectomy for cancer: a systematic review of the literature. Minerva Chir 64:135–146
4. Dantoc MM, Cox MR, Eslick GD (2012) Does minimally invasive esophagectomy (MIE) provide for comparable oncologic outcomes to open techniques? A systematic review. J Gastrointest Surg 16:486–494
5. Nagpal K, Ahmed K, Vats A, Yakoub D, James D, Ashrafian H, Darzi A, Moorthy K, Athanasiou T (2010) Is minimally invasive surgery beneficial in the management of esophageal cancer? A meta-analysis. Surg Endosc 24:1621–1629
6. Lazzarino AI, Nagpal K, Bottle A, Faiz O, Moorthy K, Aylin P (2010) Open versus minimally invasive esophagectomy: trends of utilization and associated outcomes in England. Ann Surg 252:292–298
7. Luketich JD, Pennathur A, Awais O, Levy RM, Keeley S, Shende M, Christie NA, Weksler B, Landreneau RJ, Abbas G, Schuchert MJ, Nason KS (2012) Outcomes after minimally invasive esophagectomy: review of over 1000 patients. Ann Surg 256:95–103
8. Takeuchi H, Miyata H, Gotoh M, Kitagawa Y, Baba H, Kimura W, Tomita N, Nakagoe T, Shimada M, Sugihara K, Mori M (2014) A risk model for esophagectomy using data of 5354 patients included in a Japanese Nationwide web-based database. Ann Surg 260:259–266
9. Biere SS, van Berge Henegouwen MI, Maas KW, Bonavina L, Rosman C, Garcia JR, Gisbertz SS, Klinkenbijl JH, Hollmann MW, de Lange ES, Bonjer HJ, van der Peet DL, Cuesta MA (2012) Minimally invasive versus open oesophagectomy for patients with oesophageal cancer: a multicentre, open-label, randomised controlled trial. Lancet 379:1887–1892
10. Luketich J, Pennathur A, Catalano P, Swanson S, de Hoyos A, Maddaus M, Nguyen N, Benson A, Fernando H (2009) Results of a phase II multicenter study of minimally invasive esophagectomy (Eastern Cooperative Oncology Group Study E2202). J Clin Oncol 27:15s:(suppl):15s; Abstract 4516
11. Igaki H, Kato H, Tachimori Y, Daiko H, Fukaya M, Yajima S, Nakanishi Y (2001) Clinicopathologic characteristics and survival of patients with clinical Stage I squamous cell carcinomas of the thoracic esophagus treated with three-field lymph node dissection. Eur J Cardiothorac Surg 20:1089–1094
12. Kato H, Sato A, Fukuda H, Kagami Y, Udagawa H, Togo A, Ando N, Tanaka O, Shinoda M, Yamana H, Ishikura S (2009) A phase II trial of chemoradiotherapy for stage I esophageal squamous cell carcinoma: Japan Clinical Oncology Group Study (JCOG9708). Jpn J Clin Oncol 39:638–643
13. Chen SB, Weng HR, Wang G, Yang JS, Yang WP, Liu DT, Chen YP, Zhang H (2013) Surgical treatment for early esophageal squamous cell carcinoma. Asian Pac J Cancer Prev 14:3825–3830
14. Brewin CR, Bradley C (1989) Patient preferences and randomised clinical trials. BMJ 299:313–315
15. Sobin LH, Gospodarowicz MK, Wittekind C (eds) (2009) Oesophagus including Oesophagogastric Junction, TNM classification of malignant tumors, 7th edn. Wiley-Blackwell, New York, pp 66–72
16. National Cancer Institute (2003) Common terminology criteria for adverse events version 3.0. http://ctep.cancer.gov/protocoldevelopment/electronic_applications/docs/ctcaev3.pdf. March 2003; Accessed 9 Aug 2006
17. Guo W, Zou YB, Ma Z, Niu HJ, Jiang YG, Zhao YP, Gong TQ, Wang RW (2013) One surgeon’s learning curve for video-assisted thoracoscopic esophagectomy for esophageal cancer with the patient in lateral position: how many cases are needed to reach competence? Surg Endosc 27:1346–1352
18. Tapias LF, Morse CR (2014) Minimally invasive ivor lewis esophagectomy: description of a learning curve. J Am Coll Surg 218:1130–1140
19. Nakamura K, Kato K, Igaki H, Ito Y, Mizusawa J, Ando N, Udagawa H, Tsubosa Y, Daiko H, Hironaka S, Fukuda H, Kitagawa Y (2013) Three-arm phase III trial comparing cisplatin plus 5-FU (CF) versus docetaxel, cisplatin plus 5-FU (DCF) versus radiotherapy with CF (CF-RT) as preoperative therapy for locally advanced esophageal cancer (JCOG1109, NExT study). Jpn J Clin Oncol 43:752–755
20. Mamidanna R, Bottle A, Aylin P, Faiz O, Hanna GB (2012) Short-term outcomes following open versus minimally invasive esophagectomy for cancer in England: a population-based national study. Ann Surg 255:197–203
21. Jarral OA, Purkayastha S, Athanasiou T, Zacharakis E (2010) Should thoracoscopic three-stage esophagectomy be performed in the prone or left lateral decubitus position? Interact CardioVasc Thorac Surg 13:60–65
22. Yatabe T, Kitagawa H, Yamashita K, Akimori T, Hanazaki K, Yokoyama M (2010) Better postoperative oxygenation in thoracoscopic esophagectomy in prone positioning. J Anesth 24:803–806
23. Palanivelu C, Prakash A, Senthilkumar R, Senthilnathan P, Parthasarathi R, Rajan PS, Venkatachlam S (2006) Minimally invasive esophagectomy: thoracoscopic mobilization of the esophagus and mediastinal lymphadenectomy in prone position—experience of 130 patients. J Am Coll Surg 203:7–16